Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Gain Therapeutics, Inc. (GANX) vs Pelthos Therapeutics Inc. (PTHS)

Gain Therapeutics, Inc. and Pelthos Therapeutics Inc. are both Biotechnology companies. Gain Therapeutics, Inc. and Pelthos Therapeutics Inc. are of similar size ($85.8M and $80.3M). Gain Therapeutics, Inc. has the higher net margin (0.00% vs −199.5%) and the higher return on invested capital (0.00% vs −82.3%). Across the 15 metrics below, Gain Therapeutics, Inc. leads on 8 and Pelthos Therapeutics Inc. on 7.

Valuation

Metric GANX PTHS Biotechnology median
P/E n/m n/m 7.88
P/S 397.40 1.82 11.47
P/B 6.87 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 332.17 2.92 10.73
Earnings yield (27.62%) (128.97%) (28.84%)
Free cash flow yield (24.45%) (54.04%) (23.03%)

Profitability

Metric GANX PTHS Biotechnology median
Gross margin 0.00% 78.59% 65.16%
Operating margin 0.00% (133.42%) 0.00%
Net margin 0.00% (199.50%) 0.00%
Free cash flow margin 0.00% (98.37%) 0.00%
Return on equity (268.30%) 2,161.07% (57.72%)
Return on assets (159.22%) (125.04%) (49.22%)
Return on invested capital 0.00% (82.34%) 0.00%

Growth

Metric GANX PTHS Biotechnology median
Revenue growth (TTM) 18.36% — 5.64%
EPS growth (last fiscal year) 31.46% (61.12%) —
Revenue growth, 5-year CAGR 21.79% — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric GANX PTHS Biotechnology median
Debt to equity 0.03 (46.58) 0.00
Current ratio 4.36 1.98 4.73
Net debt to EBITDA 1.10 (0.45) 0.96

Dividend

Metric GANX PTHS Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric GANX PTHS Biotechnology median
Market cap 80.30m 85.76m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack